Village-scale persistence and elimination of gambiense human African trypanosomiasis

PLoS Negl Trop Dis. 2019 Oct 28;13(10):e0007838. doi: 10.1371/journal.pntd.0007838. eCollection 2019 Oct.

Abstract

Gambiense human African trypanosomiasis (gHAT) is one of several neglected tropical diseases that is targeted for elimination by the World Health Organization. Recent years have seen a substantial decline in the number of globally reported cases, largely driven by an intensive process of screening and treatment. However, this infection is highly focal, continuing to persist at low prevalence even in small populations. Regional elimination, and ultimately global eradication, rests on understanding the dynamics and persistence of this infection at the local population scale. Here we develop a stochastic model of gHAT dynamics, which is underpinned by screening and reporting data from one of the highest gHAT incidence regions, Kwilu Province, in the Democratic Republic of Congo. We use this model to explore the persistence of gHAT in villages of different population sizes and subject to different patterns of screening. Our models demonstrate that infection is expected to persist for long periods even in relatively small isolated populations. We further use the model to assess the risk of recrudescence following local elimination and consider how failing to detect cases during active screening events informs the probability of elimination. These quantitative results provide insights for public health policy in the region, particularly highlighting the difficulties in achieving and measuring the 2030 elimination goal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Congo / epidemiology
  • Forecasting
  • Geographic Mapping
  • Health Policy
  • Humans
  • Incidence
  • Mass Screening / methods*
  • Population Density
  • Prevalence
  • Public Health
  • Trypanosoma brucei gambiense
  • Trypanosomiasis, African / epidemiology*
  • World Health Organization

Grants and funding

This work was supported by the Bill and Melinda Gates Foundation 388 (www.gatesfoundation.org) in partnership with the Task Force for Global Health 389 through the NTD Modelling Consortium [OPP1053230] (K.S.R. and M.J.K.), the Bill 390 and Melinda Gates Foundation through the Human African Trypanosomiasis Modelling 391 and Economic Predictions for Policy (HAT MEPP) project [OPP1177824] (K.S.R. and 392 M.J.K.), and EPSRC/MRC via the MathSys Centre for Doctoral Training (C.N.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.